Dublin, Oct. 03, 2016 -- Research and Markets has announced the addition of the "Global Flow Cytometry Market 2016-2020" report to their offering.
The analysts forecast the global flow cytometry market to grow at a CAGR of 9.84% during the period 2016-2020.
The report covers the present scenario and the growth prospects of the global flow cytometry market for 2016-2020. To calculate the market size, the report considers the revenue generated by the sales of instruments, reagents, and services provided for flow cytometry process. The report also includes a discussion of the key vendors operating in this market.
Increased use of multiplex-based assays will be a key trend for market growth. In clinical diagnostics and research, the analysis of serum and plasma is of prime importance for which researchers need precise yet rapid and cost-effective measurement for analysis and interpretation. Multiplex bead array assays provide quantitative analysis of large numbers of analytes. BD Cytometric Beads, for instance, allow researchers to quantify multiple proteins simultaneously. The BD CBA system also involves a wide range of fluorescence detection capabilities offered by flow cytometry and antibody-coated beads, which have the ability to efficiently capture analytes. Each bead in the array incorporates a unique fluorescence intensity for the simultaneous analysis of beads. This requires less time for analysis than traditional technologies such as ELISA and Western blotting.
According to the report, one of the key drivers for market growth will be technological advances. Flow cytometry devices have a wide range of applications in a number of areas that include immunology, pathology, molecular biology, marine biology, and plant biology. The increase in research on monoclonal antibodies and molecular diagnostics and improved understanding of immunologic factors that regulate systemic diseases have a strong impact on the growth of this market over the past five years. Technological advances have led to the development of much more effective fluorogenic markets and reagents.
Further, the report states that flow cytometry instruments are extremely expensive and require a large initial investment to procure, set up, and calibrate. Apart from the rather large initial investment that goes into these instruments, the reagents, markers, and other consumables that are required for the process for detection, apart from the software support needed to obtain quantifiable results, are also rather expensive. This translates to a high TCO (total cost of ownership) for the user. The high cost of this process will tend to be a challenge to the adoption of this technology in the healthcare and pharmaceutical sectors.
Key vendors
- Beckman Coulter
- BD
- EMD Millipore
- Luminex
- Thermo Fisher Scientific
Other prominent vendors
- Advanced Analytical Technologies
- Apogee Flow Systems
- Bio-Rad Laboratories
- Cytek Biosciences
- Cytonome
- Miltenyi Biotec
- Mindray Medical
- Sysmex Partec
- Sony Biotechnology
- Stratedigm
- TTP Labtech
For more information about this report visit http://www.researchandmarkets.com/research/cvtpfr/global_flow
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biotechnology


Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Apple Turns 50: From Garage Startup to AI Crossroads
Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
Britain Courts Anthropic Amid US Defense Department Dispute
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
UPS and Teamsters Reach Agreement to Limit Driver Severance Program
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
First Western Ship Transits Strait of Hormuz Since Iran War Began
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Cathay Pacific Holds Firm on Flight Capacity Amid Middle East Conflict and Rising Fuel Costs
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Fonterra Admits Anchor Butter "Grass-Fed" Label Misled Consumers After Greenpeace Lawsuit 



